[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f7vGypF699ZJuApZiLCzrRb3mT6RtJJUQ6f3YDsreBjo":8,"$fR0sYWQFhO-OKr1B6hc6eW3rp86x7Ds1JOo5XNi0vS-4":55,"$f-NltqjjrNHztwVJbv972Pau5dBze3OeLEktCXEFvjAA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},72205,867494,[],"https://ystcdn.venuertc.com/medical/ystApp/GjJuchDgAgQ0zSW93Z4SEvNWK5DBd53o.png","原琦","山西省肿瘤医院","消化内科","主治医师",12,0,"升结肠恶性肿瘤药品使用安全指南","","https://ystcdn.venuertc.com/venue/AI/821987f0-8cad-4b33-8347-5442b3604dd3.jpg","\u003Cdiv class=\"oncology-medicine-container\">\n  \u003Ch1 id=\"material_title\" class=\"oncology-medicine-title\">\n    升结肠恶性肿瘤药品使用安全指南\n  \u003C/h1>\n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f5fafb 60%, #e6eef5 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">药物简介：升结肠恶性肿瘤常用药\u003C/h2>\n    \u003Cp>\n      说起来，很多人都听说过用于结肠肿瘤的化疗药、靶向药和相关辅助药品。它们在抑制异常细胞生长的同时，也对身体产生多种影响。本文就汇总6个关键用药细节，包括剂型、服法、常见副作用、储存要求等，让你快速抓住安全用药的核心点。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f6f8f9 50%, #e4e9f2 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">01 常用药品类型与成分解析 💊\u003C/h2>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\u003Cstrong>化疗药物：\u003C/strong>含有成分如奥沙利铂（Oxaliplatin）、卡培他滨（Capecitabine）、氟尿嘧啶（5-FU），可静脉或口服。\u003C/li>\n      \u003Cli>\u003Cstrong>靶向药物：\u003C/strong>常用有贝伐珠单抗（Bevacizumab）、西妥昔单抗（Cetuximab）。多为静脉注射。\u003C/li>\n      \u003Cli>\u003Cstrong>辅助药品：\u003C/strong>如止吐药（昂丹司琼）、升白药（利妥昔单抗等），用于减轻药物副作用。\u003C/li>\n      \u003Cli>\u003Cstrong>剂型：\u003C/strong>包括注射剂、口服片剂、口服胶囊等。特殊片剂比如肠溶片不能掰开或咀嚼。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      正确做法：用药前核对药品的成分与剂型，按医嘱选择合适的服用方式。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #eef5f3 60%, #e4eaff 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">02 用药时间与方法细节 ⏰\u003C/h2>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        \u003Cstrong>化疗药（如卡培他滨）：\u003C/strong>餐后半小时内整片吞服，用200ml以上温水送服。肠溶药片要完整吞下。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>注射用药（如奥沙利铂）：\u003C/strong>需在医疗机构静脉滴注，不能自行处理，滴注过程中需密切观察不适改变。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>靶向药：\u003C/strong>大多按疗程周期静滴，周期长度及剂量由专业医生统一安排。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      正确做法：严格依照医嘱选择用药时间和方法，不随意更换给药途径。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f8fbfa 70%, #e7eaf4 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">03 用法用量要点和剂型适用 🎯\u003C/h2>\n    \u003Cp>\n      不同药物、不同患者用量差异很大。例如口服卡培他滨的推荐总量基于患者体表面积（mg/m\u003Csup>2\u003C/sup>），通常每天两次。注射药（如奥沙利铂）剂量按周期、体重、肾功能等计算。\n    \u003C/p>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        需要严格按照医生开具的处方用药，不可擅自增加或减少剂量。\n      \u003C/li>\n      \u003Cli>\n        一些肠溶、缓释剂型需完整吞服，不能掰开或咀嚼。口服时喝足量温水。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      特别提醒：用药期间如有漏服，及时补服，但如果临近下次服药，勿加倍补服。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f0f7fc 65%, #e6f3f7 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">04 药物相互作用：警惕联合用药 ⚠️\u003C/h2>\n    \u003Cp>\n      不少化疗和靶向药品容易与其他药品发生相互作用：\n    \u003C/p>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        \u003Cstrong>卡培他滨与抗凝药：\u003C/strong>可增强出血风险，需严密监测凝血指标。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>质子泵抑制剂（如奥美拉唑）：\u003C/strong>可能降低卡培他滨等药物在胃中的吸收效果。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>部分抗癫痫药、降压药与5-FU：\u003C/strong>有影响代谢或加强副作用的可能，避免联用或交由专业医师调配。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>维生素、保健品：\u003C/strong>部分成分可能影响药效或提升毒性，用药时务必先咨询医生或药师。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      推荐做法：服用任何新药前主动出示当前药物清单，避免擅自叠加用药。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f4faf7 80%, #e8f0fb 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">05 特殊人群用药调整 👨‍👩‍👧‍👦\u003C/h2>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        \u003Cstrong>老年患者：\u003C/strong>\n        需关注肝肾功能、体重变化，部分药物（如奥沙利铂在肾功能差时）应减量或延长用药间隔。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇与哺乳期女性：\u003C/strong>\n        绝大多数化疗药、靶向药禁忌使用，可影响胎儿/婴儿，应避孕并遵医嘱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肝肾功能下降者：\u003C/strong>\n        很多抗肿瘤药品需调整剂量，严禁自行更改。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>体重小于标准者：\u003C/strong>\n        剂量按公斤体重/表面积算，需动态调整。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      正确做法：定期复查血常规、肝肾功能，根据结果及时调整药量。\n    \u003C/p>\n    \u003Cp class=\"oncology-medicine-case\">\n      \u003Cspan class=\"oncology-medicine-case-label\">案例：\u003C/span>\n      一位66岁女性（68kg），化疗初期按标准剂量口服卡培他滨，之后根据血象变化适当调整，避免了粒细胞减少等严重副作用。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f5f7fb 60%, #eef7ee 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">06 常见不良反应与安全处理方法 🚨\u003C/h2>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        \u003Cstrong>消化道反应：\u003C/strong>口服化疗药可能引起恶心、呕吐、口腔炎，建议合理饮食，必要时联合使用抗恶心药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>骨髓抑制：\u003C/strong>如出现白细胞、血小板下降，需定期监测血常规，严重时需暂停用药并遵医嘱处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>手足综合征：\u003C/strong>部分患者长期服卡培他滨后出现皮肤红斑、脱皮，适当护肤、避免摩擦可改善。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>外周神经病变：\u003C/strong>奥沙利铂易使手脚麻木，冷刺激可加重，不适时需报告医生评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过敏反应：\u003C/strong>注射靶向药物时，若出现皮疹、呼吸异常等，需立即寻求医疗帮助。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      出现疑似严重不良反应（如持续高热、皮肤大量损伤、出血等）时，务必第一时间就医。\n    \u003C/p>\n    \u003Cp>\n      临床数据显示，卡培他滨相关的3级及以上不良反应发生率约为35%（Van Cutsem et al., 2001），规范监测能显著降低药害风险。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #fafbf5 50%, #ebf4f2 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">07 正确储存方式和药品保存 🗄️\u003C/h2>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        \u003Cstrong>药品保管：\u003C/strong>绝大部分化疗、靶向药需避光、干燥、低温保存。建议放在原包装密封箱内，防潮变质。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>高温高湿环境：\u003C/strong>如超过25℃或过于潮湿，会影响部分药品的稳定性和效果。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>有效期与弃置：\u003C/strong>定期查验药品生产日期、有效期，过期或外观改变的药品不能继续使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>儿童防护：\u003C/strong>药品必须远离儿童可触及的位置，防止误食。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      推荐做法：发现药品变色、松散、气味异常等现象时，须停止使用并及时咨问药房或医生。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f6faf7 30%, #e4f1f4 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">08 漏服与用药过量应对措施 🧠\u003C/h2>\n    \u003Cul class=\"oncology-medicine-list\">\n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong>若漏服一剂卡培他滨，可在6小时内补服；若已临近下次服药，按正常时间服下次，不可多服补救。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药过量：\u003C/strong>如不慎多服，应立即记录用药量并联系医疗机构，仔细说明具体情况，由专业人员给予处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>不适症状自查：\u003C/strong>如出现剧烈呕吐、意识模糊、呼吸异常，需尽速前往医院处理。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"oncology-medicine-tip\">\n      特别提醒：用药期间保持每日用药记录，养成核查药量的习惯，有效预防因漏服/重服造成风险。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #f8f7fa 50%, #e4f9f7 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">09 用药经验案例助理解 🌟\u003C/h2>\n    \u003Cul class=\"oncology-medicine-case\">\n      \u003Cli>\n        临床上使用卡培他滨期间，有患者出现手足皮肤损伤，调整剂量、加用护手霜后，症状明显减轻，顺利完成疗程。\n      \u003C/li>\n      \u003Cli>\n        靶向药联合化疗时，发现临床漏服切换药物导致药效波动，加强用药记录后有效避免类似问题发生。\n      \u003C/li>\n      \u003Cli>\n        一位老年患者调整剂量后，副作用减少，依从性和复诊率明显提高，整体治疗体验更佳。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #fbf8 60%, #e8f3fa 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">10 用药小结：牢记这些细节 🤗\u003C/h2>\n    \u003Col class=\"oncology-medicine-summary\">\n      \u003Cli>药品成分与剂型要核实，先看说明后用药。\u003C/li>\n      \u003Cli>使用剂量及周期必须遵医嘱，不要自行调整。\u003C/li>\n      \u003Cli>服药时间、用法及时记录，出现副作用要尽快就医。\u003C/li>\n      \u003Cli>警惕药物相互作用，补充、换用新药前要咨询药师。\u003C/li>\n      \u003Cli>过期、变质药品或外观异常时停止服用，不自行处理。\u003C/li>\n    \u003C/ol>\n    \u003Cp>\n      其实，升结肠相关药物管理的关键在于细致入微与规避盲区，只有长期坚持安全用药习惯，才能真正发挥最大药效、减少潜在危害。\n    \u003C/p>\n    \u003Cp>\n      如遇用药疑惑或身体不适，建议及时咨询专科医生或药师，保障疗效与安全。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"oncology-medicine-section\" style=\"background: linear-gradient(90deg, #fbfafc 60%, #e5f3ff 100%);\">\n    \u003Ch2 class=\"oncology-medicine-subtitle\">参考文献 🔖\u003C/h2>\n    \u003Cul class=\"oncology-medicine-ref\">\n      \u003Cli>\n        Van Cutsem, E., Twelves, C., Cassidy, J., et al. (2001). Oral capecitabine compared with intravenous 5-fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. \u003Cem>Journal of Clinical Oncology, 19\u003C/em>(21), 4097-4106.\n      \u003C/li>\n      \u003Cli>\n        Goldberg, R. M., Rothenberg, M. L., Van Cutsem, E., et al. (2007). The continuum of care: A paradigm for the management of metastatic colorectal cancer. \u003Cem>Oncologist, 12\u003C/em>(1), 38-50.\n      \u003C/li>\n      \u003Cli>\n        Benson, A. B., Venook, A. P., Al-Hawary, M. M., et al. (2018). Colon cancer, version 2.2018. \u003Cem>JNCCN—Journal of the National Comprehensive Cancer Network, 16\u003C/em>(4), 359-369.\n      \u003C/li>\n      \u003Cli>\n        Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Cem>New England Journal of Medicine, 350\u003C/em>(23), 2335-2342.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.oncology-medicine-container {\n  max-width: 820px;\n  margin: 32px auto 32px auto;\n  padding: 32px 30px 40px 30px;\n  background: #f2f5fb;\n  border-radius: 20px;\n  box-shadow: 0 2px 16px rgba(72,99,127,0.10);\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  color: #232946;\n}\n.oncology-medicine-title {\n  font-size: 2.4em;\n  font-weight: 700;\n  line-height: 1.2;\n  color: #344969;\n  margin-bottom: 26px;\n  text-align: center;\n  letter-spacing: 2px;\n}\n.oncology-medicine-section {\n  margin-bottom: 38px;\n  border-radius: 14px;\n  padding: 24px 30px 22px 30px;\n  position: relative;\n  background-size: cover;\n  background-repeat: no-repeat;\n  box-shadow: 0 1px 8px rgba(60,90,120,0.04);\n}\n.oncology-medicine-subtitle {\n  font-size: 1.5em;\n  font-weight: 600;\n  margin: 0 0 18px 0;\n  color: #206080;\n  letter-spacing: 1px;\n  display: flex;\n  align-items: center;\n}\n.oncology-medicine-list {\n  margin: 0 0 10px 0;\n  padding-left: 22px;\n}\n.oncology-medicine-list li {\n  font-size: 1.1em;\n  margin-bottom: 10px;\n  line-height: 1.7;\n}\n.oncology-medicine-tip {\n  background: #eaf5f3;\n  color: #177962;\n  font-size: 1.05em;\n  border-left: 4px solid #3b9083;\n  padding: 9px 15px;\n  border-radius: 6px;\n  margin-top: 12px;\n  margin-bottom: 0;\n}\n.oncology-medicine-case {\n  background: #fff7ee;\n  color: #975912;\n  font-size: 1em;\n  border-left: 4px solid #f4bc74;\n  padding: 8px 13px 8px 13px;\n  border-radius: 6px;\n  margin: 15px 0 0 0;\n}\n.oncology-medicine-case-label {\n  font-weight: bold;\n  margin-right: 8px;\n}\n.oncology-medicine-summary {\n  margin-left: 18px;\n  margin-bottom: 12px;\n  font-size: 1.1em;\n  line-height: 1.9;\n}\n.oncology-medicine-ref {\n  margin: 0 0 0 14px;\n  font-size: 1em;\n  color: #666d81;\n  line-height: 1.8;\n}\n@media (max-width: 700px) {\n  .oncology-medicine-container {\n    padding: 16px 7px 14px 7px;\n    border-radius: 10px;\n  }\n  .oncology-medicine-section {\n    padding: 16px 8px 12px 9px;\n    border-radius: 7px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"oncology-medicine-container\">\n  \u003Ch1 id=\"material_title\" class=\"oncology-medicine-title\">",752,"2025-11-12 01:48:22","升结肠恶性肿瘤, 化疗药物, 靶向药物, 用药安全, 不良反应","本指南详细讲述升结肠恶性肿瘤相关药品的使用安全，包含药物成分、用法用量、不良反应等重要信息，帮助患者及家属安全用药","2025-11-18 13:56:40",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]